SCOTUS Gives Temporary Relief to Abortion Pill Manufacturers, Louisiana AG Responds
The U.S. Supreme Court, through Justice Samuel Alito, issued a temporary administrative stay allowing the abortion pill mifepristone to continue being prescribed online and mailed while legal challenges proceed. This action pauses a Fifth Circuit Court of Appeals decision that had reinstated in-person dispensing requirements for the drug. The stay will remain in effect until May 11, giving the Court time to consider the manufacturers' emergency appeal.
- ▪The Fifth Circuit Court of Appeals ruled that Louisiana has standing to challenge the FDA's 2023 changes to mifepristone distribution rules.
- ▪Justice Samuel Alito granted a temporary stay allowing mifepristone to be prescribed online and mailed, effective until May 11, 2026.
- ▪The manufacturers, Danco Laboratories and GenBioPro, appealed to the Supreme Court after the Fifth Circuit blocked mail distribution of the drug.
- ▪Louisiana Attorney General Liz Murrill and Alliance Defending Freedom are challenging the FDA's expanded access to mifepristone.
- ▪Alito set a Thursday deadline for Louisiana officials to respond to the drugmakers' emergency applications.
Opening excerpt (first ~120 words) tap to expand
SCOTUS Gives Temporary Relief to Abortion Pill Manufacturers, Louisiana AG Responds By Jennifer Oliver O'Connell | 1:10 PM on May 04, 2026 The opinions expressed by contributors are their own and do not necessarily represent the views of RedState.com. AP Photo/Amanda Andrade-Rhoades As RedState reported on Saturday, the Fifth Circuit Court of Appeals ruled that Louisiana has standing in its legal battle to reverse the 2023 changes the Food and Drug Administration (FDA) made to its risk evaluation and mitigation strategy (REMS) ruling that allowed Mifepristone —the abortion pill — to be distributed without medical supervision over-the-counter and through the U.S. Mail.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at RedState.